Labs nationwide are struggling to meet the processing demands of surging coronavirus disease 2019 (COVID-19) tests, causing long delays; levels of antibodies against SARS-CoV-2, the virus that causes COVID-19, were found to drop dramatically across the first 3 months of infection; suspected opioid-related overdoses have more than doubled in Wisconsin amid the pandemic.
Reported by The Associated Press, labs nationwide are struggling to meet the processing demands of surging coronavirus disease 2019 (COVID-19) tests, causing long delays that experts note is affecting the pandemic response. As of Wednesday, the number of confirmed US COVID-19 cases has approached nearly 4 million, with states such as California and Florida experiencing all-time highs in daily case tolls. These surges have caused significant workloads for US labs, which can cause testing result lags of up to 2 weeks.
In findings from a research letter published this week in the New England Journal of Medicine, levels of antibodies against SARS-CoV-2, the virus that causes COVID-19, dropped dramatically across the first 3 months of infection. Reported by CIDRAP, those examined experienced mild illness, with antibody levels indicated to decrease by about half every 73 days. At this rate, researchers note that antibody resistance would be depleted within a year. However, experts in a separate article published in The New York Times note that the possibility of being infected again with COVID-19 is very unlikely, although the long-term possibility is still unknown.
Amid the COVID-19 pandemic, there have been more than double as many suspected opioid-related overdoses in Wisconsin compared with last year, which health officials say can be potentially attributed to growing feelings of stress and isolation. Reported by The Associated Press, there have been 325 suspected overdoses from March through July 13 compared with 150 during this time frame last year, according to preliminary figures of Wisconsin’s Department of Health Services (DHS). DHS officials additionally highlighted that their analysis of calls to 211 Wisconsin, a state help line, has identified the pandemic, housing, mental health, and addiction as the top 4 concerns.
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
CMS released a final rule to help patients obtain Children’s Health Insurance Program (CHIP) coverage and issued a proposed rule to update Medicare payment policies and rates for inpatient rehabilitation facilities; debate over if gift card incentives are acceptable in health care marketing.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Dr Chakra Chaulagain: PFS Is the "Bare Minimum," but OS Is Ideal for Choosing Between MM Therapies
March 28th 2024Response rates are important when choosing between therapies to treat multiple myeloma (MM), but improvement overall survival (OS) is the ideal, said Chakra Chaulagain MD, FACP, hematologist/oncologist, Maroone Cancer Center of Cleveland Clinic Florida.
Read More